BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 34556550)

  • 1. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance.
    Garus A; Autexier C
    RNA; 2021 Dec; 27(12):1441-1458. PubMed ID: 34556550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human dyskerin: beyond telomeres.
    Angrisani A; Vicidomini R; Turano M; Furia M
    Biol Chem; 2014 Jun; 395(6):593-610. PubMed ID: 24468621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing.
    Mochizuki Y; He J; Kulkarni S; Bessler M; Mason PJ
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10756-61. PubMed ID: 15240872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskeratosis congenita: a disorder of defective telomere maintenance?
    Walne AJ; Marrone A; Dokal I
    Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita.
    Zeng XL; Thumati NR; Fleisig HB; Hukezalie KR; Savage SA; Giri N; Alter BP; Wong JM
    Hum Mol Genet; 2012 Feb; 21(4):721-9. PubMed ID: 22058290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
    Brault ME; Lauzon C; Autexier C
    Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.
    Carrillo J; González A; Manguán-García C; Pintado-Berninches L; Perona R
    Clin Transl Oncol; 2014 Jun; 16(6):529-38. PubMed ID: 24065372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.
    Parry EM; Alder JK; Lee SS; Phillips JA; Loyd JE; Duggal P; Armanios M
    J Med Genet; 2011 May; 48(5):327-33. PubMed ID: 21415081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A telomerase component is defective in the human disease dyskeratosis congenita.
    Mitchell JR; Wood E; Collins K
    Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dyskeratosis congenita mutations in dyskerin, NHP2 and NOP10 on assembly of H/ACA pre-RNPs.
    Trahan C; Martel C; Dragon F
    Hum Mol Genet; 2010 Mar; 19(5):825-36. PubMed ID: 20008900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation.
    Penzo M; Rocchi L; Brugiere S; Carnicelli D; Onofrillo C; Couté Y; Brigotti M; Montanaro L
    FASEB J; 2015 Aug; 29(8):3472-82. PubMed ID: 25934701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
    Vulliamy TJ; Dokal I
    Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-guided isomerization of uridine to pseudouridine--pseudouridylation.
    Yu YT; Meier UT
    RNA Biol; 2014; 11(12):1483-94. PubMed ID: 25590339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation.
    MacNeil DE; Lambert-Lanteigne P; Autexier C
    Nucleic Acids Res; 2019 Jun; 47(10):5368-5380. PubMed ID: 30931479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new human dyskerin isoform with cytoplasmic localization.
    Angrisani A; Turano M; Paparo L; Di Mauro C; Furia M
    Biochim Biophys Acta; 2011 Dec; 1810(12):1361-8. PubMed ID: 21820037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminal extension of dyskerin is a dyskeratosis congenita mutational hotspot that modulates interaction with telomerase RNA and subcellular localization.
    Qin J; Garus A; Autexier C
    Hum Mol Genet; 2024 Feb; 33(4):318-332. PubMed ID: 37879098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyskerin is a component of the Arabidopsis telomerase RNP required for telomere maintenance.
    Kannan K; Nelson AD; Shippen DE
    Mol Cell Biol; 2008 Apr; 28(7):2332-41. PubMed ID: 18212040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.